| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Guyer William | Chief Development Officer | C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY | /s/ Joseph Douglas Lyon, as attorney-in-fact for William Guyer. | 04 Mar 2026 | 0001879013 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CORT | Common Stock | Award | +498 | +40% | $35.97* | 1,733 | 02 Mar 2026 | Direct | F1, F2, F3 | |
| transaction | CORT | Common Stock | Award | +498 | +29% | $0.000000* | 2,231 | 02 Mar 2026 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026. |
| F2 | In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. |
| F3 | Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| F4 | Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. |
The power of attorney under which this form was signed is on file with the Commission.